Pharma stock jumps 6% after receiving export certificate for its API productPharma stock jumps 6% after receiving export certificate for its API product

Introduction:

Pharma stock has received a Certificate of Suitability (CEP) from EDQM for its API product, Quetiapine Fumarate. This approval enhances its export potential, allowing it to expand in European and global markets, strengthening its position in the pharmaceutical industry.

Share Price movement of IOL Chemicals and Pharmaceuticals:

On March 6, 2025, IOL Chemicals & Pharmaceuticals Ltd opened at ₹341.90, reaching a high of ₹349.00, up 6% from its previous close of ₹327.70, and a low of ₹337.80. The stock is currently trading at ₹343.05, with a market cap of ₹2,013.89 crore.

IOL Chemicals and Pharmaceuticals received export certificate:

IOL Chemicals and Pharmaceuticals Limited has received a Certificate of Suitability (CEP) from the European Directorate for the Quality of Medicines & Health Care (EDQM) for its API product, Quetiapine Fumarate. This certification, issued on March 4, 2025, enhances the company’s export capabilities.  

With the CEP approval, the company can now export Quetiapine Fumarate, an antipsychotic drug used to treat mental health disorders, to European and other global markets that accept CEPs. This milestone strengthens its presence in the international pharmaceutical industry, expanding growth opportunities.

Also Read: Ai stock jumps 15% after signing MoU with Myren Inc. at MWC Barcelona 2025

Recent news About IOL Chemicals and Pharmaceuticals:

​IOL Chemicals and Pharmaceuticals Limited has announced a 2-for-1 stock split, with the ex-trade date set for March 11, 2025. This means that each existing share will be subdivided into two shares, effectively halving the share price while doubling the number of shares held by investors. 

Stock performance of IOL Chemicals and Pharmaceuticals for Period of 1 week, 6 months and 1 year:

Over the past week, the stock of IOL Chemicals and Pharmaceuticals saw a marginal rise of 0.23%, reflecting slight stability. However, in the last six months, it declined 29.7%, indicating significant pressure. Over the past year, the stock has dropped 17.2%, highlighting a downward trend.

Also Read: Vijay Kedia stock jumps 15% after securing ₹448 Cr water infra project in UP

Shareholding pattern of IOL Chemicals and Pharmaceuticals:

All values in %	Dec-24	Sep-24	Jun-24
Promoters	70.91	70.91	70.91
FII	4.19	4.08	3.87
DII	12.98	12.99	12.71
Retail & others	11.91	12	12.51

About IOL Chemicals and Pharmaceuticals:

IOL Chemicals and Pharmaceuticals is a leading API manufacturer and specialty chemicals producer. It specializes in key pharmaceutical ingredients, including pain management and antipsychotic drugs. With a strong export presence, it serves global markets, ensuring high-quality standards and regulatory compliance in pharmaceutical manufacturing.

Disclaimer: The above article is written for educational purposes, and the companies’ data mentioned in the article may change with respect to time The securities quoted are exemplary and are not recommendatory.